Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.600
+0.100 (6.67%)
Feb 13, 2026, 11:59 AM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 Dec '16
Innovative Cell-based Technologies
1.37M
Innovative Cell-based Technologies Growth
124.34%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2018FY 2017FY 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '18 Dec '17 Dec '16
United States
1.37M
United States Growth
124.34%